The UK Health Security Agency (UKHSA) held a webinar in collaboration with NHS England about the new Meningococcal B (MenB) Vaccination Service on Tuesday 7th July. The webinar was recorded and is now available to watch on demand. View the webinar The Advanced service has been commissioned to support the administration of MenB vaccines to [...]
The post MenB vac: On-demand webinar appeared first on Community Pharmacy England.
Every community pharmacy owner has an NHS Parent Organisation Code (POC). This is the unique code that identifies your parent organisation within the NHS. If you own a single pharmacy, you still have a POC. If you own multiple pharmacies, each pharmacy site should be correctly linked to the same POC. POCs are usually four [...]
The post Reminder: Knowing your NHS POC code? appeared first on Community Pharmacy England.
Community Pharmacy England has been working urgently with NHS England to improve Meningococcal B (MenB) vaccine allocation and ordering ahead of the service launch next week. Further to our earlier news story regarding vaccine allocation and ordering, we have been in regular dialogue with NHS England seeking to ensure that the initial ordering and allocation [...]
The post MenB vac update: vaccine allocation and ordering appeared first on Community Pharmacy England.
The Department of Health and Social Care (DHSC) has today (15/07/2026) confirmed the following initial list of price concessions for July 2026: Drug Pack size Price concession Aspirin 75mg tablets 28 £1.72 Atomoxetine 60mg capsules 28 £6.40 Atomoxetine 80mg capsules 28 £8.62 Azathioprine 50mg tablets 56 £1.51 Betahistine 16mg tablets 84 £1.85 Bicalutamide 150mg tablets [...]
The post July 2026 Price Concessions 1st Update appeared first on Community Pharmacy England.
Cases of iatrogenic botulism have been reported following the therapeutic or cosmetic use of botulinum toxin containing products where the toxin’s effect extends beyond the area of treatment. Botulism caused by botulinum toxin is rare but can be life threatening. Symptoms can take up to four weeks to develop and may typically include difficulty breathing [...]
The post MHRA Drug Safety Update: Botulinum toxin type A products appeared first on Community Pharmacy England.
Recent Comments